Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

July 16, 2026 CE Webinar (PHARMACISTS)



The Premier July 16, 2026 CE webinar will be held from 12 - 1 pm EDT. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
 

“Weight” a Minute! Medication Therapy in Pediatric Patients with Obesity

Speaker: Norman E Fenn III, PharmD, BCPS, BCPPS, FASHP, FPPA, Clinical Associate Professor, Manchester University College of Health Professions, Nursing & Pharmacy, Pediatric Clinical Pharmacist, Parkview Women’s & Children's Hospital, Fort Wayne, IN

ACPE Universal Activity Number: 0122-0000-26-035-L01-P [0.1 CEU] [1 Contact Hr.]

Important: When registering for a CE activity, please select the program that aligns with your profession (Pharmacist or Pharmacy Technician). Choosing the correct program is essential to ensure your CE credit is processed accurately and prevents delays in reporting to CPE Monitor.

Date: Jul 16, 2026 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Jul 16, 2026 12:10 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Requirements for CE Credit

CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.

Support/Credits

Financial support: Premier, Inc. has received no outside support for the administration of this program.

 

 

Thu, Jul 16, 2026
 

   

Objectives

  • Identify contributing factors to obesity in pediatric patients
  • Classify guideline recommendations for obesity pharmacotherapy in pediatric patients
  • Review nonpharmacologic management of obesity in pediatric patients
  • Discuss complications and challenges associated with GLP-1 agonist therapy in pediatric patients

Speaker(s)/Author(s)

Norman E Fenn III, PharmD/BCPS/BCPPS/FASHP/FPPA
Clinical Associate Professor/Pediatric Clinical Pharmacist, Manchester University College of Health Profession

Activity Number

0122-0000-26-035-L01-P
Date: 07/16/26
Time: 12:00 PM - 01:00 PM

CE Hours

1.00